Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Short term Debt (2022 - 2024)

Historic Short term Debt for Gossamer Bio (GOSS) over the last 3 years, with Q1 2024 value amounting to $9.6 million.

  • Gossamer Bio's Short term Debt fell 1742.87% to $9.6 million in Q1 2024 from the same period last year, while for Mar 2024 it was $9.6 million, marking a year-over-year decrease of 1742.87%. This contributed to the annual value of $11.6 million for FY2023, which is 0.0% changed from last year.
  • According to the latest figures from Q1 2024, Gossamer Bio's Short term Debt is $9.6 million, which was down 1742.87% from $11.6 million recorded in Q4 2023.
  • Over the past 5 years, Gossamer Bio's Short term Debt peaked at $11.6 million during Q4 2022, and registered a low of $9.6 million during Q1 2024.
  • Over the past 3 years, Gossamer Bio's median Short term Debt value was $11.6 million (recorded in 2022), while the average stood at $11.3 million.
  • Its Short term Debt has fluctuated over the past 5 years, first changed by 0.0% in 2023, then crashed by 1742.87% in 2024.
  • Over the past 3 years, Gossamer Bio's Short term Debt (Quarter) stood at $11.6 million in 2022, then changed by 0.0% to $11.6 million in 2023, then decreased by 17.43% to $9.6 million in 2024.
  • Its Short term Debt was $9.6 million in Q1 2024, compared to $11.6 million in Q4 2023 and $11.6 million in Q3 2023.